MindMaze Therapeutics Holding S.A. (0QKQ.L) LSE
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
MindMaze Therapeutics Holding S.A.
Address
Chemin de Roseneck 5
Lausanne, 1006
Switzerland
Phone
+41 21 532 08 60
Sector
Healthcare
Industry
Biotechnology
Employees
31
First IPO Date
January 18, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Zachery W. Henderson | CEO & Director | 0 | 1973 |
| Alexandre Capet | Chief Operating & Strategy Officer | 0 | 1973 |
| Frédéric Condolo | Chief Technology Officer | 0 | 1973 |
| Jeremy Meinen | Chief Financial Officer | 0 | 1989 |
AD
Description
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
AD